Back to resultsA Study to Assess the Impact of Implementing Modified Early Warning Score in Terms of Competency and Self-efficacy of Nurses at ILBS, Delhi
Primary Purpose
Liver Diseases
Status
Unknown status
Phase
Not Applicable
Locations
India
Study Type
Interventional
Intervention
training porogram
Sponsored by
About this trial
This is an interventional prevention trial for Liver Diseases
Eligibility Criteria
Inclusion Criteria:
- registered nurses working in general, semi-private and private ward nurses willing to participate
Exclusion Criteria:
- registered nurses who will not be present at the time of data collection. pull out staffs.
Sites / Locations
- Institute of Liver & Biliary SciencesRecruiting
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
staff nurses
Arm Description
firstly pre-test would conducted for the group then after 7 days post-test would be conducted for the same group intervention which will be given: training on modified early warning score to staff nurses and marking of physiological parameters on MEWS chart
Outcomes
Primary Outcome Measures
to assess the impact of MEWS on competency and self-efficacy of nurses before and after implementing MEWS
pre-test would be taken to assess previous level and post-test to measure the change in competency
Secondary Outcome Measures
Full Information
NCT ID
NCT05088044
First Posted
October 11, 2021
Last Updated
March 30, 2022
Sponsor
Institute of Liver and Biliary Sciences, India
1. Study Identification
Unique Protocol Identification Number
NCT05088044
Brief Title
A Study to Assess the Impact of Implementing Modified Early Warning Score in Terms of Competency and Self-efficacy of Nurses at ILBS, Delhi
Official Title
A Quasi Experimental Study to Assess the Impact of Implementing Modified Early Warning Score in Terms of Competency and Self-efficacy of Nurses at ILBS, Delhi
Study Type
Interventional
2. Study Status
Record Verification Date
October 2021
Overall Recruitment Status
Unknown status
Study Start Date
November 11, 2021 (Actual)
Primary Completion Date
April 15, 2022 (Anticipated)
Study Completion Date
April 15, 2022 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Institute of Liver and Biliary Sciences, India
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
In this study nurses will be taught regarding Modified Early Warning Score and how to mark the involved physiological parameters in the MEWS chart and then scoring will be given i.e MEWS score and according to the score intervention would be taken by nurses by communicating with other health team members. this scoring will allow nurses to assess early deterioration and early ICU admission and at last nurses will be asked regarding the barriers or facilitators they faced while performing MEWS score.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Liver Diseases
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
one group pre-test post-test design.
Masking
None (Open Label)
Allocation
N/A
Enrollment
82 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
staff nurses
Arm Type
Experimental
Arm Description
firstly pre-test would conducted for the group then after 7 days post-test would be conducted for the same group intervention which will be given: training on modified early warning score to staff nurses and marking of physiological parameters on MEWS chart
Intervention Type
Other
Intervention Name(s)
training porogram
Intervention Description
training on modified early warning signs will be given to staff nurses and they will be asked to mark physiological parameters on MEWS chart and identify detrioration
Primary Outcome Measure Information:
Title
to assess the impact of MEWS on competency and self-efficacy of nurses before and after implementing MEWS
Description
pre-test would be taken to assess previous level and post-test to measure the change in competency
Time Frame
7 days
10. Eligibility
Sex
All
Minimum Age & Unit of Time
21 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
registered nurses working in general, semi-private and private ward nurses willing to participate
Exclusion Criteria:
registered nurses who will not be present at the time of data collection. pull out staffs.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Anjali Gautam, BSc
Phone
01146300000
Email
anjaligautam.9524@gmail.com
Facility Information:
Facility Name
Institute of Liver & Biliary Sciences
City
New Delhi
State/Province
Delhi
ZIP/Postal Code
110070
Country
India
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Anajali Gautam, BSc
Phone
01146300000
Email
anjaligautam.9524@gmail.com
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
A Study to Assess the Impact of Implementing Modified Early Warning Score in Terms of Competency and Self-efficacy of Nurses at ILBS, Delhi
We'll reach out to this number within 24 hrs